Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Isatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple Myeloma

Massachusetts General Hospital · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
multiple-myeloma
relapsed cancer, refractory multiple myeloma, multiple myeloma, relapsed/refractory, relapsed and refractory, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 918788
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.